Second-round bids for medical diagnostics company Beckman Coulter (BEC.N) were due on Wednesday, three sources familiar with the situation said. Commitment letters from banks to finance private equity-led deals were also required to be submitted on Wednesday, one of those sources said. The sources declined to be named because the process is not public. Two private equity consortia have been pursuing Beckman -- one made up of Blackstone (BX.N) and TPG Capital, and the second made up of Apollo [APOLO.UL] and Carlyle [CYL.UL], sources previously told Reuters. The company has also received interest from diversified industrial company Danaher Corp (DHR.N).
Source
